No document available.
Abstract :
[en] Novel entities like stem-cells and related medical therapies have become key sites of biomedical innovation and capital accumulation (Salter et al. 2015). Little attention has yet been paid to how biological materials circulate and acquire value, what kinds of value, and for whom. Following Appadurai (1986)’s methodological principle that things-in-motion illuminate their human and social context, we follow the trajectories and analyze the social life of human cells as they leave bodies to be stored, modified, transported, frozen or injected.
Disciplines :
Life sciences: Multidisciplinary, general & others
Political science, public administration & international relations
Law, criminology & political science: Multidisciplinary, general & others
Commentary :
References
Appadurai, A. (Ed.). (1986). The social life of things: Commodities in cultural perspective. Cambridge University Press.
Büscher, M., & Urry, J. (2009). Mobile methods and the empirical. European Journal of Social Theory, 12(1), 99-116.
Hicks, D. (2010). The material-cultural turn. The Oxford handbook of material culture studies, 25-98.
Marcus, G. E. (1995). Ethnography in/of the world system: The emergence of multi-sited ethnography. Annual review of anthropology, 24(1), 95-117.
Salter, B., Zhou, Y., & Datta, S. (2015). Hegemony in the marketplace of biomedical innovation: consumer demand and stem cell science. Social Science & Medicine, 131, 156-163.
Yates‐Doerr, E. (2019). Whose global, which health? Unsettling collaboration with careful equivocation. American anthropologist, 121(2), 297-310.
